<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2019-11-10-15</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-3437</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Частота выявления и клиническая значимость  латентного инфекционного эндокардита у пациентов с аортальным стенозом</article-title><trans-title-group xml:lang="en"><trans-title>Detection rate and clinical significance of latent  infective endocarditis in patients with aortic stenosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8656-3191</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иртюга</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Irtyuga</surname><given-names>O. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иртюга Ольга Борисовна — кандидат медицинских наук, ведущий научный сотрудник  НИЛ кардиомиопатий.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">olgir@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0783-2112</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чистякова</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Chistyakova</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чистякова Вера Ивановна — студентка лечебного  факультета.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">vera.chistyakova@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9641-2656</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тенчурина</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Tenchurina</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тенчурина Анна Олеговна — студентка лечебного  факультета.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">atenchurina@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2066-6542</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солнцев</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Solntsev</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Солнцев Владислав Николаевич — старший научный сотрудник НИЛ математического моделирования.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">vs5962@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8723-2765</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кушнарева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kushnareva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кушнарева Екатерина Алексеевна — клинический  ординатор по   специальности    “кардиология”.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">Bondarenko.E94@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4715-7585</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жидулева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhiduleva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жидулева Екатерина Викторовна — научный сотрудник НИО некоронарогенных  заболеваний сердца.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">Zhiduleva.kate@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6168-8895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малев</surname><given-names>Э. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Malev</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малев Эдуард Геннадиевич — доктор медицинских наук, ведущий научный сотрудник НИО некоронарогенных заболеваний  сердца.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">edwardmalev@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0996-4119</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Antonova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антонова Ирина Владимировна — кандидат медицинских наук,  доцент кафедры патологии, врач-патологоанатом, заведующая патологоанатомическим отделением.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">antonova_iv@almazovcentre.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8199-0813</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордеев</surname><given-names>М. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordeev</surname><given-names>M. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гордеев Михаил Леонидович — главный кардиохирург, заведующий научно-исследовательским отделом кардиоторакальной хирургии заведующий кафедрой хирургических болезней.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">gordeev_ml@almazovcentre.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0009-9106</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демченко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Demchenko</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демченко Елена Алексеевна — доктор медицинских наук, заведующая НИЛ реабилитации, научный руководитель Отделения восстановительного лечения Детского лечебно-реабилитационного комплекса,  руководитель научно-клинического объединения  реабилитации, профессор кафедры внутренних болезней.</p><p>Санкт-Петербург.</p></bio><bio xml:lang="en"><p>St.  Petersburg.</p></bio><email xlink:type="simple">demchenko_ea@almazovcentre.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр им. В.А. Алмазова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый  Санкт-Петербургский государственный  медицинский  университет  им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>18</day><month>07</month><year>2019</year></pub-date><volume>0</volume><issue>11</issue><fpage>10</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Иртюга О.Б., Чистякова В.И., Тенчурина А.О., Солнцев В.Н., Кушнарева Е.А., Жидулева Е.В., Малев Э.Г., Антонова И.В., Гордеев М.Л., Демченко Е.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Иртюга О.Б., Чистякова В.И., Тенчурина А.О., Солнцев В.Н., Кушнарева Е.А., Жидулева Е.В., Малев Э.Г., Антонова И.В., Гордеев М.Л., Демченко Е.А.</copyright-holder><copyright-holder xml:lang="en">Irtyuga O.B., Chistyakova V.I., Tenchurina A.O., Solntsev V.N., Kushnareva E.A., Zhiduleva E.V., Malev E.G., Antonova I.V., Gordeev M.L., Demchenko E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/3437">https://russjcardiol.elpub.ru/jour/article/view/3437</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценка частоты послеоперационной диагностики инфекционного эндокардита (ИЭ) у пациентов с аортальным стенозом (АС) и анализ влияния поздней диагностики на исходы заболевания.</p></sec><sec><title>Материал  и методы</title><p>Материал  и методы. Проведен  ретроспективный  анализ  регистра  из 1764 больных с АС, сформированного на основании трансторакальных  эхокардиографических (ЭхоКГ) исследований, выполненных в 2009-2011гг.  За 8-летний период  наблюдения  прооперировано 679 пациентов,  из них у 131 человека был диагностирован ИЭ. Пациенты были разделены на подгруппы в зависимости от морфологии  клапана и от времени  верификации  ИЭ — до или после операции.  ИЭ, впервые выявленный в послеоперационном периоде, рассматривался как латентный ИЭ.</p></sec><sec><title>Результаты</title><p>Результаты. Среди больных с АС доля лиц с ИЭ составила  лишь 3,7%, однако при  патоморфологическом исследовании  признаки  ИЭ выявлены  у 19,3%. В 58,8%  случаев  ИЭ был выявлен  впервые  в послеоперационном периоде. В 66,2% случаев латентный ИЭ диагностирован у больных с врожденным пороком сердца  (ВПС) — бикуспидальным АК (БАК).  В группе пациентов с известным до операции  ИЭ были более низкие значения гемоглобина,  эритроцитов и более высокий уровень креатинина. В 28% случаев по результатам  гистологического исследования диагностирован  перенесенный ИЭ неактивной стадии, у 26,5% включенных в анализ — 3 стадия активности, среди которых у 16% пациентов ИЭ был латентным. Однокомпонентная антибактериальная терапия (АБТ) проводилась у 40,5% больных, 2-компонентная — у 50,0%, 3-компонентная  — у 9,5%.  Медиана  продолжительности  АБТ составила  14  дней  (от  7 до 42). Восьмилетняя  выживаемость  пациентов  с ИЭ составила  91,2%.  Из 9 умерших лишь у 5 (56%) диагноз ИЭ был известен  до оперативного  лечения. </p></sec><sec><title>Заключение</title><p>Заключение. Более половины больных, оперированных по поводу порока АК, имели латентное течение ИЭ и как следствие позднюю диагностику заболевания,  что могло  повлиять  на  среднесрочную  выживаемость.   Большая  часть включенных в анализ лиц с латентным течением ИЭ имели ВПС-БАК, что требует разработки  дополнительных мер  профилактики ИЭ у данной категории пациентов.  Различные подходы к АБТ латентного ИЭ в клинической практике определяют актуальность проведения дополнительных исследований, направленных на унификацию подходов к АБТ в этой клинической ситуации.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim.  To assess the  detection  rate  of infective endocarditis  (IE) in postoperative period in patients with aortic stenosis  (AS) and analyze the impact of late diagnosis on disease outcomes.</p></sec><sec><title>Material and methods</title><p>Material and methods. A retrospective analysis of the register of 1764 patients with AS, formed on the basis  of transthoracic echocardiographic (echo)  tests  in2009-2011, was performed. During the 8-year follow-up period, 679 patients were operated  on;  IE  was  diagnosed  in  131  people.  Patients  were  divided  into subgroups depending  on the  valve morphology  and  the  time of IE verification before   or  after  surgery.   IE, first  detected  in  the  postoperative  period,  was considered as latent IE.</p></sec><sec><title>Results</title><p>Results. Among patients  with AS, the proportion of people  with IE was only 3,7%, however, pathomorphological examination revealed  IE signs in 19,3%. In 58,8% ofcases, IE was detected for the first time in the postoperative period. In 66,2% of cases,latent IE was diagnosed in patients with congenital heart disease (CHD) — bicuspidaortic valve (BAV). In the group of patients with known IE before surgery, there were lower levels of hemoglobin, erythrocytes and a higher level of creatinine. According to the results of a histological examination, inactive IE was diagnosed in 28% of cases. In 26,5% of patients  stage  3 activity IE was defined,  among  which latent course  was recorded in 16%. Single-agent antibiotic therapy (ABT) was carried out in 40,5% of patients, dual-agent ABT — in 50,0%, triple-agent — in 9,5%. The median duration of ABT was 14 days (7 to 42). The eight-year survival rate for patients with IE was 91,2%. Of the 9 deaths, only 5 (56%) had a diagnosis of IE before surgery.</p></sec><sec><title>Conclusion</title><p>Conclusion. More than half of the patients operated on for AV defects  had a latent course  of IE and,  as  a  result,  late  diagnosis,  which could  affect  medium-term survival. Most of the people  with latent IE included in the analysis had CHD-BAV, which requires the development of IE preventive measures in this patient population. Various  approaches to  the  ABT of latent  IE in clinical practice   determine  the relevance  of additional  studies  aimed  at unification the  ABT approaches in this clinical setting.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекционный эндокардит</kwd><kwd>аортальный  стеноз</kwd><kwd>бикуспидальный аортальный клапан</kwd></kwd-group><kwd-group xml:lang="en"><kwd>infective endocarditis</kwd><kwd>aortic stenosis</kwd><kwd>bicuspid aortic valve</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа  выполнена  при  поддержке  гранта  Российского фонда фундаментальных исследований (проект 17-03-013-18)</funding-statement><funding-statement xml:lang="en">This work was supported by a grant from the Russian Foundation for Basic Research (project 17-03-013-18)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Habib G, Lancellotti P, Antunes M, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European heart journal. 2015;36(44):3075-128. doi:10.15829/1560-4071-2016-5-65-116.</mixed-citation><mixed-citation xml:lang="en">Habib G, Lancellotti P, Antunes M, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European heart journal. 2015; 36(44), 3075-3128, doi: 10.15829/1560-4071-2016-5-65-116</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009;169:463-73. doi:10.1001/archinternmed.2008.603.</mixed-citation><mixed-citation xml:lang="en">Murdoch D, Corey R, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009; 169:463–473. doi: 10.1001/archinternmed.2008.603</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vincent LL, Otto CM. Infective endocarditis: update on epidemiology, outcomes and management. Curr Cardiol Rep. 2018;20:86. doi:10.1007/s11886-018-1043-2.</mixed-citation><mixed-citation xml:lang="en">Vincent LL, Otto CM. Infective endocarditis: update on epidemiology, outcomes and management. Curr Cardiol Rep. 2018; 20:86. doi: 10.1007/s11886-018-1043-2</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation.1993;87(2 Suppl):121-6.</mixed-citation><mixed-citation xml:lang="en">Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993; 87(2 Suppl):I121-6. PubMed PMID: 8425318.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgartner H, Falk V, Bax J, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease, European Heart Journal. 2017;38:2739-91. doi:10.1093/eurheartj/ehx391.</mixed-citation><mixed-citation xml:lang="en">Baumgartner H, Falk V, Bax J, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease, European Heart Journal, Volume 38, Issue 36, 21. 2017; Pages 2739–2791, doi: 10.1093/eurheartj/ehx391</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández Guerrero ML, Álvarez B, Manzarbeitia F, et al. Infective endocarditis at autopsy: a review of pathologic manifestations and clinical correlates. Medicine (Baltimore). 2012;91(3):152-64. doi:10.1097/MD.0b013e31825631ea.</mixed-citation><mixed-citation xml:lang="en">Fernández Guerrero ML, Álvarez B, Manzarbeitia F, et al. Infective endocarditis at autopsy: a review of pathologic manifestations and clinical correlates. Medicine (Baltimore). 2012; 91 (3):152—64, doi: 10.1097/MD.0b013e31825631ea.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23. doi:10.1016/j.echo.2008.11.029.</mixed-citation><mixed-citation xml:lang="en">Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009; 22:1-23. doi:10.1016/j.echo.2008.11.029</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8. doi:10.1086/313753.</mixed-citation><mixed-citation xml:lang="en">Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30:633–638 doi: 10.1086/313753</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gálvez-Acebal J, López-Cortés LE. Infective endocarditis: New forms of the disease, new therapeutic options. Enferm Infecc Microbiol Clin. 2019. doi:10.1016/j.eimc.2019.04.002.</mixed-citation><mixed-citation xml:lang="en">Gálvez-Acebal J, López-Cortés LE. Infective endocarditis: New forms of the disease, new therapeutic options. Enferm Infecc Microbiol Clin. 2019; doi: 10.1016/j.eimc.2019.04.002</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lin A, Kyaw H, Lin K, et al. Trends in Epidemiology: Analysis of Risk Factors and Outcomes of Infective Endocarditis: A Retrospective Study (2009-2015). Cureus. 2019;11(1):e3910. doi:10.7759/cureus.3910.</mixed-citation><mixed-citation xml:lang="en">Lin A, Kyaw H, Lin K, et al. Trends in Epidemiology: Analysis of Risk Factors and Outcomes of Infective Endocarditis: A Retrospective Study (2009–2015). Cureus. 2019; 11(1): e3910. DOI: 10.7759/cureus.3910</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pericart L, Bernard A, Bourguignon T, et al. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves. The American Journal of Cardiology. 2017;119(11):1854-61. doi:10.1016/j.amjcard.2017.02.039.</mixed-citation><mixed-citation xml:lang="en">Pericart L, Bernard A, Bourguignon T, et al. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves. The American Journal of Cardiology, 2017; 119(11), pp.1854-1861. doi: 10.1016/j.amjcard.2017.02.039</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Muñoz P, Kestler M, De Alarcon A, et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore). 2015;94(43):e1816. doi:10.1097/MD.0000000000001816.</mixed-citation><mixed-citation xml:lang="en">Muñoz P, Kestler M, De Alarcon A, et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore). 2015; 94(43):e1816. Published 2015 Oct 30. doi: 10.1097/MD.0000000000001816</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Becerra-Munoz VM, Ruíz-Morales J, Rodríguez-Bailón I, et al. Endocarditis infecciosa sobre válvula aórtica bicúspide: características clínicas, complicaciones y pronóstico. Enferm Infecc Microbiol Clin. 2016;35:645-50. doi:10.1016/j.eimc.2016.06.017.</mixed-citation><mixed-citation xml:lang="en">Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009; 169:463–73 doi: 10.1001/archinternmed.2008.603</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year singlecenter experience. Thorac Cardiovasc Surg. 2010;139:665-73. doi:10.1016/j.jtcvs.2009.07.026.</mixed-citation><mixed-citation xml:lang="en">Becerra-Munoz VM, Ruíz-Morales J, Rodríguez-Bailón I, et al. Endocarditis infecciosa sobre válvula aórtica bicúspide: características clínicas, complicaciones y pronóstico. Enferm Infecc Microbiol Clin. 2016. doi: 10.1016/j.eimc.2016.06.017</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year singlecenter experience. Thorac Cardiovasc Surg 2010; 139:665–73, doi: 10.1016/j.jtcvs.2009.07.026.</mixed-citation><mixed-citation xml:lang="en">Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year singlecenter experience. Thorac Cardiovasc Surg 2010; 139:665–73, doi: 10.1016/j.jtcvs.2009.07.026.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
